9984:TSESoftBank Group Corp. Analysis
Data as of 2026-03-09 - not real-time
¥3,541.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
SoftBank Group trades well below its 12‑month high, with a current price around ¥3,540 versus a median analyst target of ¥5,800, implying a substantial upside. The stock’s low price‑to‑earnings multiple—well under the industry average—combined with a modest price‑to‑book ratio suggests it is trading at a discount. Technical signals are mixed: the RSI in the mid‑30s points to modest oversold pressure, while the MACD remains bearish and the 20‑day SMA sits just above the price, indicating short‑term downside risk.
The balance sheet is a mixed picture: massive cash reserves are offset by a very high debt‑to‑equity ratio and negative operating and free cash flow, raising concerns about dividend sustainability. Volatility is elevated and beta exceeds one, reflecting sensitivity to market swings. However, strategic assets such as Arm and the Vision Fund provide a growth catalyst, especially as AI licensing revenue gains momentum.
The balance sheet is a mixed picture: massive cash reserves are offset by a very high debt‑to‑equity ratio and negative operating and free cash flow, raising concerns about dividend sustainability. Volatility is elevated and beta exceeds one, reflecting sensitivity to market swings. However, strategic assets such as Arm and the Vision Fund provide a growth catalyst, especially as AI licensing revenue gains momentum.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram
- RSI indicating oversold but not yet rebound
- Proximity to near‑term support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant upside potential versus target price
- Low valuation multiples relative to peers
- Growth upside from Arm licensing and AI exposure
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic holdings and long‑term AI play
- Large cash buffer despite high leverage
- Potential for dividend reinstatement if cash flow improves
Key Metrics & Analysis
Financial Health
Revenue Growth8.20%
Profit Margin48.17%
P/E Ratio6.6
ROE26.02%
ROA0.69%
Debt/Equity132.43
P/B Ratio1.3
Op. Cash Flow¥-64625999872
Free Cash Flow¥-53278248960
Industry P/E18.3
Technical Analysis
TrendNeutral
RSI37.0
Support¥3,436.00
Resistance¥4,954.00
MA 20¥4,194.45
MA 50¥4,236.68
MA 200¥3,908.48
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89
Valuation
Target Price¥5,568.47
Upside/Downside57.26%
GradeUndervalued
TypeBlend
Dividend Yield0.28%
Risk Assessment
Beta1.33
Volatility77.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.